Cargando…

Are we getting to lipid targets in real life?

Detalles Bibliográficos
Autores principales:	Katsiki, Niki, Mikhailidis, Dimitri P., Athyros, Vasilis G, Hatzitolios, Apostolos I., Karagiannis, Asterios, Banach, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298327/ https://www.ncbi.nlm.nih.gov/pubmed/22419917 http://dx.doi.org/10.5114/aoms.2010.17073

Ejemplares similares

The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings
por: Athyros, Vasilios G., et al.
Publicado: (2012)

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?
por: Katsiki, Niki, et al.
Publicado: (2013)

IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?
por: Athyros, Vasilios G, et al.
Publicado: (2011)

Off target effects of statins shape total mortality?
por: Athyros, Vasilios G., et al.
Publicado: (2016)

Is There a Role for Hypolipidaemic Drug Therapy in the Prevention or Treatment of Microvascular Complications of Diabetes?
por: Mitsiou, Eydoxia K, et al.
Publicado: (2012)

Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic
por: Katsiki, Niki, et al.
Publicado: (2020)

More Good News on Statins and COVID-19
por: Katsiki, Niki, et al.
Publicado: (2021)

Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!
por: Katsiki, Niki, et al.
Publicado: (2019)

Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment
por: Athyros, Vasilios G, et al.
Publicado: (2011)

Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases
por: Tziomalos, Konstantinos, et al.
Publicado: (2011)

Rectus Sheath Hematoma: A Simplified Emergency Surgical Approach
por: Mantelas, Michael, et al.
Publicado: (2011)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study
por: Athyros, Vasilios G., et al.
Publicado: (2013)

Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice?
por: Katsiki, Niki, et al.
Publicado: (2017)

Potato consumption is associated with total and cause-specific mortality: a population-based cohort study and pooling of prospective studies with 98,569 participants
por: Mazidi, Mohsen, et al.
Publicado: (2020)

Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action
por: Athyros, Vasilios Gabriel, et al.
Publicado: (2016)

Dietary patterns, plasma vitamins and Trans fatty acids are associated with peripheral artery disease
por: Mazidi, Mohsen, et al.
Publicado: (2017)

Adiposity mediates the association between whole grain consumption, glucose homeostasis and insulin resistance: findings from the US NHANES
por: Mazidi, Mohsen, et al.
Publicado: (2018)

Association of Empirical Dietary Atherogenic Indices with All-Cause and Cause-Specific Mortality in a Multi-Ethnic Adult Population of the United States
por: Mazidi, Mohsen, et al.
Publicado: (2019)

Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study
por: Katsiki, Niki, et al.
Publicado: (2016)

Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Apolipoprotein B/Apolipoprotein A-I Ratio Is a Better Predictor of Cancer Mortality Compared with C-Reactive Protein: Results from Two Multi-Ethnic US Populations
por: Mazidi, Mohsen, et al.
Publicado: (2020)

Serum anti-inflammatory and inflammatory markers have no causal impact on telomere length: a Mendelian randomization study
por: Mazidi, Mohsen, et al.
Publicado: (2021)

Hyperuricaemia in Cardiovascular Diseases: A Passive or an Active Player?
por: Katsiki, Niki, et al.
Publicado: (2015)

Diabetes and carotid artery disease: a narrative review
por: Katsiki, Niki, et al.
Publicado: (2020)

Perivascular adipose tissue in cardiovascular diseases
por: Katsiki, Niki, et al.
Publicado: (2020)

Implementation of Guidelines for the Management of Arterial Hypertension. The Impulsion Study
por: Karagiannis, Asterios, et al.
Publicado: (2009)

CETP inhibition in the REVEAL trial: could we aim higher?
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
por: Athyros, Vassilios G., et al.
Publicado: (2011)

Effects of Lifestyle Measures, Antiobesity Agents, and Bariatric Surgery on Serological Markers of Inflammation in Obese Patients
por: Tziomalos, Konstantinos, et al.
Publicado: (2010)

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients(§)
por: Athyros, Vasilios G, et al.
Publicado: (2007)

Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk?
por: Anagnostis, Panagiotis, et al.
Publicado: (2023)

Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters
por: Athyros, Vasilios G, et al.
Publicado: (2012)

Statin Intolerance—We Know Everything, We Know Nothing
por: Banach, Maciej
Publicado: (2022)

A Greater Flavonoid Intake Is Associated with Lower Total and Cause-Specific Mortality: A Meta-Analysis of Cohort Studies
por: Mazidi, Mohsen, et al.
Publicado: (2020)

Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate
por: Hobbs, FD Richard, et al.
Publicado: (2016)

The Role of Psychobiological and Neuroendocrine Mechanisms in Appetite Regulation and Obesity
por: Paspala, Ioanna, et al.
Publicado: (2012)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

The impact of nuts consumption on glucose/insulin homeostasis and inflammation markers mediated by adiposity factors among American adults
por: Mazidi, Mohsen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p2go2ggborap9o86un85qt9pt3